Home / Superinvestors / Baupost Group
Baupost Group
Value
$10.81B
Positions
44
Top 10 weight
66.0%
Holdings
44 stocks| Stock | Shares | Value ▲ | Reported Price | Current Price | vs Reported | 52W | Weight |
|---|---|---|---|---|---|---|---|
| VESPER HEALTHCARE ACQSTN COR | 1,320,000 | $3.491M | $2.64 | - | - | - | 0.0% |
| REDBALL ACQUISITION CORP | 1,650,000 | $3.696M | $2.24 | - | - | - | 0.0% |
| VISTA ENERGY SAB DE CV | 1,951,132 | $4.995M | $2.56 | $55.84 | +2081.2% | $43.88 – $79.25 | 0.0% |
| REINVENT TECHNOLOGY PARTNERS | 1,000,000 | $11.38M | $11.38 | - | - | - | 0.1% |
| DRAGONEER GROWTH OPPTY CORP | 1,000,000 | $11.42M | $11.42 | - | - | - | 0.1% |
| PERSHING SQUARE TONTINE HLDG | 1,944,444 | $18.67M | $9.60 | - | - | - | 0.2% |
| Radius Global Infrastructure, Inc. | 1,501,342 | $19.29M | $12.85 | - | - | - | 0.2% |
| INVESTINDUSTRIAL ACQUISITION | 2,100,000 | $21.59M | $10.28 | - | - | - | 0.2% |
| TRILOGY METALS INC NEW | 12,182,568 | $24.37M | $2.00 | $1.94 | -3.0% | $1.94 – $6.89 | 0.2% |
| BROADSTONE ACQUISITION CORP | 2,970,000 | $31.16M | $10.49 | - | - | - | 0.3% |
| HORIZON ACQUISITION CORPORAT | 3,500,000 | $37.59M | $10.74 | - | - | - | 0.3% |
| REINVENT TECHNOLOGY PARTNERS | 3,500,000 | $42.88M | $12.25 | - | - | - | 0.4% |
| AVANTI ACQUISITION CORP | 4,000,000 | $43.36M | $10.84 | - | - | - | 0.4% |
| VESPER HEALTHCARE ACQSTN COR | 3,960,000 | $44.79M | $11.31 | - | - | - | 0.4% |
| REDBALL ACQUISITION CORP | 4,950,000 | $53.91M | $10.89 | - | - | - | 0.5% |
| AJAX I | 5,000,000 | $62.05M | $12.41 | - | - | - | 0.6% |
| VERITIV CORP | 3,564,439 | $74.11M | $20.79 | - | - | - | 0.7% |
| COLONY CAP INC NEW | 24,212,959 | $116.5M | $4.81 | - | - | - | 1.1% |
| HEALTHPEAK PROPERTIES INC | 4,000,200 | $120.9M | $30.23 | $19.98 | -33.9% | $15.78 – $22.82 | 1.1% |
| ALPHABET INC | 79,580 | $139.4M | $1,751.88 | $292.52 | -83.3% | $273.14 – $399.04 | 1.3% |
| FIDELITY NATL FINL INC | 3,800,000 | $148.5M | $39.09 | $43.41 | +11.1% | $38.65 – $57.61 | 1.4% |
| LIBERTY MEDIA CORP DELAWARE | 3,500,000 | $151.2M | $43.19 | - | - | - | 1.4% |
| VERINT SYS INC | 2,290,000 | $153.8M | $67.18 | - | - | - | 1.4% |
| THERAVANCE BIOPHARMA INC | 8,735,168 | $155.2M | $17.77 | - | - | - | 1.4% |
| ADVANTAGE SOLUTIONS INC | 12,500,000 | $161.2M | $12.90 | - | - | - | 1.5% |
| Fox Corp. | 5,680,307 | $164M | $28.88 | $61.11 | +111.6% | $44.39 – $67.76 | 1.5% |
| PARAMOUNT GLOBAL | 4,700,000 | $175.1M | $37.26 | - | - | - | 1.6% |
| ATARA BIOTHERAPEUTICS INC | 9,108,988 | $178.8M | $19.63 | - | - | - | 1.7% |
| LIBERTY GLOBAL PLC | 7,657,205 | $185.5M | $24.22 | - | - | - | 1.7% |
| NEXSTAR MEDIA GROUP INC | 2,085,000 | $227.7M | $109.19 | $207.94 | +90.4% | $154.70 – $253.64 | 2.1% |
| SS&C TECH HLDGS | 3,305,784 | $240.5M | $72.75 | $79.50 | +9.3% | $62.05 – $89.62 | 2.2% |
| META PLATFORMS INC | 920,000 | $251.3M | $273.16 | $641.69 | +134.9% | $525.72 – $777.59 | 2.3% |
| LIBERTY MEDIA CORP DELAWARE | 6,484,867 | $282.2M | $43.51 | - | - | - | 2.6% |
| MARATHON PETE CORP | 7,690,721 | $318.1M | $41.36 | $414.65 | +902.5% | $162.63 – $484.92 | 2.9% |
| TRANSLATE BIO INC | 18,044,239 | $326.2M | $18.08 | - | - | - | 3.0% |
| PERSHING SQUARE TONTINE HLDG | 12,707,924 | $352.3M | $27.72 | - | - | - | 3.3% |
| PG&E CORP | 30,657,601 | $382M | $12.46 | $13.25 | +6.3% | $11.95 – $19.11 | 3.5% |
| MICRON TECHNOLOGY INC | 5,222,000 | $392.6M | $75.18 | $778.31 | +935.3% | $201.37 – $1,213.56 | 3.6% |
| VIASAT INC | 16,288,959 | $531.8M | $32.65 | $67.72 | +107.4% | $30.35 – $89.81 | 4.9% |
| Fox Corp. | 22,186,950 | $646.1M | $29.12 | $68.42 | +135.0% | $48.79 – $76.11 | 6.0% |
| QORVO INC | 4,440,095 | $738.3M | $166.27 | - | - | - | 6.8% |
| INTEL CORP | 18,185,569 | $906M | $49.82 | $59.66 | +19.8% | $33.62 – $140.94 | 8.4% |
| LIBERTY GLOBAL PLC | 54,555,407 | $1.29B | $23.65 | - | - | - | 11.9% |
| EBAY INC | 31,115,223 | $1.564B | $50.25 | $120.92 | +140.6% | $79.41 – $125.15 | 14.5% |
Combines 45 filed positions into 44 CUSIPs. Positions split across delegated managers are summed.
13F reports long positions only (including long options; shorts and cash excluded) as of quarter end.
Other reported positions
1 items| Stock | Type | Amount / Par | Value |
|---|---|---|---|
| THERAVANCE BIOPHARMA INC | Principal (bond/note) | 30,000,000 | $28.4M |
Bonds, notes, preferred/depositary shares, zero-value positions and options (call/put) are listed for completeness but are not counted in the value or position totals — shares only, value above zero, options excluded, preferred excluded (the Dataroma convention). Options are shown as the underlying share count and its value, not as contracts.